Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451

Clinical trial NCT01196676 · COMPLETED

Trial details

NCT number: NCT01196676
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2010-08-01
Primary completion: 2011-04-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.